Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bevacizumab in ovarian cancer: A critical review of phase III studies.
Rossi L, Verrico M, Zaccarelli E, Papa A, Colonna M, Strudel M, Vici P, Bianco V, Tomao F. Rossi L, et al. Among authors: tomao f. Oncotarget. 2017 Feb 14;8(7):12389-12405. doi: 10.18632/oncotarget.13310. Oncotarget. 2017. PMID: 27852039 Free PMC article. Review.
Positron Emission Tomography (PET) radiotracers in oncology--utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC).
Miele E, Spinelli GP, Tomao F, Zullo A, De Marinis F, Pasciuti G, Rossi L, Zoratto F, Tomao S. Miele E, et al. Among authors: tomao s, tomao f. J Exp Clin Cancer Res. 2008 Oct 17;27(1):52. doi: 10.1186/1756-9966-27-52. J Exp Clin Cancer Res. 2008. PMID: 18928537 Free PMC article. Review.
Emerging role of pemetrexed in ovarian cancer.
Tomao F, Panici PB, Frati L, Tomao S. Tomao F, et al. Among authors: tomao s. Expert Rev Anticancer Ther. 2009 Dec;9(12):1727-35. doi: 10.1586/era.09.141. Expert Rev Anticancer Ther. 2009. PMID: 19954283 Review.
Phase I-II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines.
Vici P, Fabi A, Metro G, Sergi D, Giannarelli D, Di Lauro L, Bepler G, Tomao F, Cognetti F, Conti F, Lopez M. Vici P, et al. Among authors: tomao f. Cancer Chemother Pharmacol. 2011 Mar;67(3):687-93. doi: 10.1007/s00280-010-1369-y. Epub 2010 May 29. Cancer Chemother Pharmacol. 2011. PMID: 20512334 Clinical Trial.
[Specificity of action of anticancer agents].
Vici P, Sergi D, Pizzuti L, Vincenzoni C, Vizza E, Tomao F, Morace N, Toglia G, Mancini E, Baiocco E, Di Lauro L, Botti C, Sindico S, Lopez M. Vici P, et al. Among authors: tomao f. Clin Ter. 2011;162(2):137-49. Clin Ter. 2011. PMID: 21533321 Italian.
Current knowledge and open issues regarding bevacizumab in gynaecological neoplasms.
Bellati F, Napoletano C, Gasparri ML, Ruscito I, Marchetti C, Pignata S, Tomao F, Benedetti Panici P, Nuti M. Bellati F, et al. Among authors: tomao f. Crit Rev Oncol Hematol. 2012 Jul;83(1):35-46. doi: 10.1016/j.critrevonc.2011.09.006. Epub 2011 Nov 4. Crit Rev Oncol Hematol. 2012. PMID: 22056314 Review.
Intraperitoneal chemotherapy by ultrasound-guided direct puncture in recurrent ovarian cancer: feasibility, compliance, and complications.
Benedetti-Panici P, Perniola G, Marchetti C, Pernice M, Donfrancesco C, Di Donato V, Tomao F, Palaia I, Graziano M, Basile S, Bellati F. Benedetti-Panici P, et al. Among authors: tomao f. Int J Gynecol Cancer. 2012 Jul;22(6):1069-74. doi: 10.1097/IGC.0b013e31825736b2. Int J Gynecol Cancer. 2012. PMID: 22665042 Clinical Trial.
Breast cancer metastatic to the pituitary gland: a case report.
Spinelli GP, Lo Russo G, Miele E, Prinzi N, Tomao F, Antonelli M, Giangaspero F, Stati V, Strudel M, Tomao S. Spinelli GP, et al. Among authors: tomao s, tomao f. World J Surg Oncol. 2012 Jul 9;10:137. doi: 10.1186/1477-7819-10-137. World J Surg Oncol. 2012. PMID: 22776141 Free PMC article.
Breast cancer risk after exposure to fertility drugs.
Lo Russo G, Spinelli GP, Tomao S, Rossi B, Frati L, Panici PB, Vici P, Codacci Pisanelli G, Tomao F. Lo Russo G, et al. Among authors: tomao s, tomao f. Expert Rev Anticancer Ther. 2013 Feb;13(2):149-57. doi: 10.1586/era.12.181. Expert Rev Anticancer Ther. 2013. PMID: 23406556 Review.
170 results